Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Fecal Microbiota Transplantation for Severe Clostridium Difficile Associated Colitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Both genders are eligible for study~2. Age 18 years and older~3. Able to provide written, informed consent~4. Confirmed diagnosis of severe CDAD as defined above~Exclusion Criteria:~(If any of the following apply, the subject MUST NOT enter the study):~1. Pregnant or lactating women~2. Need for prolonged antibiotics for other cause~3. Other known etiology for diarrhea, or clinical infection with other known enteric pathogens~4. Active, chronic conditions such as: Inflammatory bowel disease, Crohn's disease, Short bowel syndrome, Ulcerative or ischemic colitis~5. Laxatives or motility-altering drugs within 12 hours of enrolment~6. Clinically unstable. Hemodynamic instability defined as hypotension (mean arterial pressure \< 60) not responsive to fluids.~7. Any condition that, in the opinion of the investigator, would preclude safe participation in the trial or compromise the quality of the data obtained.~8. Immune suppression, HIV, hematological or solid malignancy (chemotherapy in the past 3 months).~9. Prior colon surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- fecal microbiota transplant (Type: EXPERIMENTAL): fecal microbiota transplantation

Based on this trial design, predict the completion outcome and termination type (if applicable).